---
title: "TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255907950.md"
description: "According to the Zhitong Finance APP, TIANYU PHARM announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as \"Nuode Pharmaceutical\") recently received the \"Drug Registration Certificate\" for Candesartan Cilexetil Tablets issued by the National Medical Products Administration. Candesartan Cilexetil Tablets are indicated for primary hypertension"
datetime: "2025-09-04T08:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255907950.md)
  - [en](https://longbridge.com/en/news/255907950.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255907950.md)
---

# TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration

According to the Zhitong Finance APP, TIANYU PHARM (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" for Candesartan Cilexetil Tablets issued by the National Medical Products Administration. Candesartan Cilexetil Tablets are indicated for primary hypertension

### Related Stocks

- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)

## Related News & Research

- [China’s Jinlihua Electric Soars by Limit After Unveiling Plan to Foray Into Commercial Aerospace Field](https://longbridge.com/en/news/287036981.md)
- [The 'Elon Musk Effect' Could Send SpaceX Stock Into Wild Swings After IPO Even If Starlink Makes 'Billions' In Profit, Warns Expert](https://longbridge.com/en/news/286923494.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [BREAKINGVIEWS-SpaceX seals private market’s triumph over public](https://longbridge.com/en/news/286936344.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)